Triple

T6251176
Position Surface form Disambiguated ID Type / Status
Subject Regeneron Pharmaceuticals E140048 entity
Predicate developsTreatmentFor P69333 FINISHED
Object age-related macular degeneration LITERAL FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: age-related macular degeneration | Statement: [Regeneron Pharmaceuticals, developsTreatmentFor, age-related macular degeneration]
PD Predicate disambiguation gpt-5-mini-2025-08-07
Target predicate: developsTreatmentFor
Context triple: [Regeneron Pharmaceuticals, developsTreatmentFor, age-related macular degeneration]
  • A. treatment
    Indicates that one entity is used as a medical or therapeutic intervention to address, manage, or cure a condition affecting another entity.
  • B. treats
    Indicates that one entity provides medical care or therapeutic intervention to another entity.
  • C. exportTreatment
    Indicates the action or process of sending or transferring a treatment (such as a medical, data, or procedural treatment) from one system, location, or context to another for external use or application.
  • D. importTreatment
    Indicates that one entity brings or transfers a treatment or therapeutic intervention into another context, system, or location for use or application.
  • E. hasCommonTreatment
    Indicates that two or more entities share at least one treatment method or therapeutic approach in common.
  • F. None of above. chosen

Provenance (4 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69c008b4858c819095b0199114a9a87b completed March 22, 2026, 3:20 p.m.
NER Named-entity recognition batch_69c0633fb2ac8190b71b8e35fa923300 completed March 22, 2026, 9:46 p.m.
PD Predicate disambiguation batch_69c056037bf88190a0a3fe7429345d0b completed March 22, 2026, 8:50 p.m.
PDg Predicate description generation batch_69c056df95ac8190bc5efe050d3af864 completed March 22, 2026, 8:53 p.m.
Created at: March 22, 2026, 4:24 p.m.